Benzothiazole | CAS:95-16-9
Benzothiazole
- 名称:苯并噻唑; 1,3-硫氮杂茚 | Benzothiazole
- CAS号:95-16-9
- 别名:
- 分子式:C7H5NS
- 分子量:135.19
- EINESC号:202-396-2
产品描述
物理化学性质
熔点 | 2 ºC |
---|---|
水溶性 | 微溶 |
沸点 | 231 ºC |
密度 | 1.238 |
折射率 | 1.641-1.644 |
安全数据
危险品标志 | Xn |
---|---|
危险类别码 | R20/21/22 |
安全说明书 | S36/37 |
SDS
来源 | SDS样本 |
---|---|
没有数据 | 没有数据 |
产品合成路线
更多
名称 | CAS号 |
---|
更多
文章
同行评议文献
In vivo kinetics of [18F](N-methyl)benperidol: a novel PET tracer for assessment of dopaminergic D2-like receptor binding.S M Moerlein et al.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 17(8), 833-845 (1997-08-01)
[123I]IBZM SPECT in patients treated with typical and atypical neuroleptics: relationship to drug plasma levels and extrapyramidal side effects.R Schlösser et al.Psychiatry research, 75(2), 103-114 (1997-11-14)
Prolactin plasma levels and D2-dopamine receptor occupancy measured with IBZM-SPECT.S Schlegel et al.Psychopharmacology, 124(3), 285-287 (1996-04-01)
In vivo measurement of D2 receptor density and affinity for 18F-(3-N-methyl)benperidol in the rat striatum with a PET system for small laboratory animals.Susanne Nikolaus et al.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 44(4), 618-624 (2003-04-08)
A comparison of D2 receptor specific binding in obese and normal-weight individuals using PET with (N-[(11)C]methyl)benperidol.Sarah A Eisenstein et al.Synapse (New York, N.Y.), 67(11), 748-756 (2013-05-08)
Hypothermia associated with antipsychotic drug use: a clinical case series and review of current literature.Peter Kreuzer et al.Journal of clinical pharmacology, 52(7), 1090-1097 (2011-10-01)
[The neuroleptic malignant syndrome].S Dammers et al.Deutsche medizinische Wochenschrift (1946), 120(50), 1739-1742 (1995-12-15)
Behavioural interactions between 5-hydroxytryptophan, neuroleptic agents and 5-HT receptor antagonists in modifying rodent responding to aversive situations.B Costall et al.British journal of pharmacology, 116(7), 2989-2999 (1995-12-01)
Benperidol for schizophrenia.S Leucht et al.The Cochrane database of systematic reviews, (2)(2), CD003083-CD003083 (2005-04-23)
Analysis of pharmacology data and the prediction of adverse drug reactions and off-target effects from chemical structure.Andreas Bender et al.ChemMedChem, 2(6), 861-873 (2007-05-05)
Imaging of dopamine receptors with [123I]iodobenzamide single-photon emission-computed tomography in neuroleptic malignant syndrome.M Jauss et al.Movement disorders : official journal of the Movement Disorder Society, 11(6), 726-728 (1996-11-01)
[Leukopenia associated with butyrophenones. A successful treatment of psychoses with pulsed administration of neuroleptics].M Grube et al.Der Nervenarzt, 70(9), 838-841 (1999-10-16)
Validation of the reference tissue model for estimation of dopaminergic D2-like receptor binding with [18F](N-methyl)benperidol in humans.Jo Ann V Antenor-Dorsey et al.Nuclear medicine and biology, 35(3), 335-341 (2008-03-22)
Specific, reversible binding of [18F]benperidol to baboon D2 receptors: PET evaluation of an improved 18F-labeled ligand.S M Moerlein et al.Nuclear medicine and biology, 22(6), 809-815 (1995-08-01)
Benperidol for schizophrenia.S Leucht et al.The Cochrane database of systematic reviews, (1)(1), CD003083-CD003083 (2002-03-01)
Radiation dosimetry of [18F] (N-methyl)benperidol as determined by whole-body PET imaging of primates.S M Moerlein et al.Nuclear medicine and biology, 24(4), 311-318 (1997-05-01)
Bilateral increase in striatal dopamine D2 receptor density in the 6-hydroxydopamine-lesioned rat: a serial in vivo investigation with small animal PET.Susanne Nikolaus et al.European journal of nuclear medicine and molecular imaging, 30(3), 390-395 (2003-03-14)
Imaging of striatal dopamine D(2) receptors with a PET system for small laboratory animals in comparison with storage phosphor autoradiography: a validation study with (18)F-(N-methyl)benperidol.S Nikolaus et al.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 42(11), 1691-1696 (2001-11-07)
Characterization of extrastriatal D2 in vivo specific binding of [¹⁸F](N-methyl)benperidol using PET.Sarah A Eisenstein et al.Synapse (New York, N.Y.), 66(9), 770-780 (2012-04-27)
Radiation dosimetry of N-([11C]methyl)benperidol as determined by whole-body PET imaging of primates.Jo Ann V Antenor-Dorsey et al.European journal of nuclear medicine and molecular imaging, 35(4), 771-778 (2007-12-12)
[Effect of activation tasks on acute neuroleptic-induced akathisia].O Gruber et al.Der Nervenarzt, 71(1), 30-37 (2000-03-01)
Complete dopamine D2 receptor occupancy without extrapyramidal side effects under benperidol.Carlos Schönfeldt-Lecuona et al.Journal of clinical psychopharmacology, 24(1), 97-98 (2004-01-08)
Voltammetric determination of droperidol and benperidol.I Biryol et al.Journal of pharmaceutical and biomedical analysis, 15(11), 1695-1701 (1997-07-01)
[D2-dopamine receptor upregulation and treatment response under neuroleptic therapy].J Schröder et al.Fortschritte der Neurologie-Psychiatrie, 68 Suppl 1, S42-S45 (2000-07-25)
Gender differences in D2 dopamine receptor binding in drug-naive patients with schizophrenia: an [123I]iodobenzamide single photon emission computed tomography study.J Schröder et al.Psychiatry research, 75(2), 115-123 (1997-11-14)
备注
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
名称 | CAS号 |
---|
相关产品
相关资讯
问
热门标签
询 单
请 填 写 相 关 信 息
- 请填写产品名称!
- CAS号
- 请正确填写公司名称!
- 请正确填写联系人!
- 请正确填写联系电话!
- 请正确填写联系邮箱!
- 请描述您的问题!